These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 6193366

  • 1. Pharmacology of ASL-8052, a novel beta-adrenergic receptor antagonist with an ultrashort duration of action.
    Gorczynski RJ, Shaffer JE, Lee RJ.
    J Cardiovasc Pharmacol; 1983; 5(4):668-77. PubMed ID: 6193366
    [Abstract] [Full Text] [Related]

  • 2. Cardiovascular pharmacology of ACC-9089--a novel, ultra-short-acting, beta-adrenergic receptor antagonist.
    Gorczynski RJ, Vuong A.
    J Cardiovasc Pharmacol; 1984; 6(4):555-64. PubMed ID: 6206307
    [Abstract] [Full Text] [Related]

  • 3. [Atenolol, its cardioselective property for adrenergic beta-receptor blocking action and effect on the cardiac function (author's transl)].
    Kanno M, Nakaya H, Hattori Y, Izumi T, Nishimura T, Sakai K, Abiko Y.
    Nihon Yakurigaku Zasshi; 1980 Oct; 76(7):621-32. PubMed ID: 6111522
    [Abstract] [Full Text] [Related]

  • 4. Beta-adrenoreceptor antagonist potency and pharmacodynamics of ASL-8123, the primary acid metabolite of esmolol.
    Shaffer JE, Quon CY, Gorczynski RJ.
    J Cardiovasc Pharmacol; 1988 Feb; 11(2):187-92. PubMed ID: 2452313
    [Abstract] [Full Text] [Related]

  • 5. Beta-blocking and hemodynamic effects of ASL-8052.
    Gorczynski RJ, Murthy VS, Hwang TF.
    J Cardiovasc Pharmacol; 1984 Feb; 6(6):1548-59. PubMed ID: 6084788
    [Abstract] [Full Text] [Related]

  • 6. Vanidilol: a vanilloid-type vasorelaxant and ocular hypotensive beta-adrenoceptor blocker with partial beta-2-agonist activity.
    Sheu MM, Wu BN, Ho WC, Hong SJ, Chen SJ, Lin YT, Chen IJ.
    Pharmacology; 1997 Apr; 54(4):211-24. PubMed ID: 9211567
    [Abstract] [Full Text] [Related]

  • 7. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
    Hicks PE, Cavero I, Manoury P, Lefevre-Borg F, Langer SZ.
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
    [Abstract] [Full Text] [Related]

  • 8. Beta-adrenoceptor antagonist activity of 3-methoxyisoprenaline.
    Bassett JR.
    Br J Pharmacol; 1971 Jan; 41(1):113-21. PubMed ID: 4396127
    [Abstract] [Full Text] [Related]

  • 9. Adrenoceptor-blocking activity and cardiohemodynamic effects of carvedilol in animals.
    Kawada T, Ishibashi T, Nakazawa M, Satoh S, Imai S.
    J Cardiovasc Pharmacol; 1990 Jul; 16(1):147-53. PubMed ID: 1696657
    [Abstract] [Full Text] [Related]

  • 10. A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug.
    Brittain RT, Levy GP.
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):681-4. PubMed ID: 10948
    [Abstract] [Full Text] [Related]

  • 11. A beta-adrenoceptor blocking agent, befunolol as a partial agonist in isolated organs.
    Takayanagi I, Koike K.
    Gen Pharmacol; 1985 Aug; 16(3):265-7. PubMed ID: 2862092
    [Abstract] [Full Text] [Related]

  • 12. Vasomolol: an ultra short-acting and vasorelaxant vanilloid type beta 1-adrenoceptor antagonist.
    Lin YT, Wu BN, Wu JR, Lo YC, Chen LC, Chen IJ.
    J Cardiovasc Pharmacol; 1996 Jul; 28(1):149-57. PubMed ID: 8797149
    [Abstract] [Full Text] [Related]

  • 13. Pharmacodynamics and onset of action of esmolol in anesthetized dogs.
    Quon CY, Gorczynski RJ.
    J Pharmacol Exp Ther; 1986 Jun; 237(3):912-8. PubMed ID: 2872328
    [Abstract] [Full Text] [Related]

  • 14. [Pharmacological properties of dl-2-(3'-t-butylamino-2'-hydroxypropylthio)-4-(5'-carbamoyl-2'-thienyl) thiazole hydrochloride (S-596), a new beta-adrenergic blocking agent (author's transl)].
    Hara Y, Sato E, Miyagishi A, Aono S, Nakatani H.
    Nihon Yakurigaku Zasshi; 1979 Oct; 75(7):707-20. PubMed ID: 94296
    [Abstract] [Full Text] [Related]

  • 15. Pharmacology of nadolol (SQ 11725), a beta-adrenergic antagonist lacking direct myocardial depression.
    Lee RJ, Evans DB, Baky SH, Laffan RJ.
    Eur J Pharmacol; 1975 Oct; 33(2):371-82. PubMed ID: 241655
    [Abstract] [Full Text] [Related]

  • 16. Pharmacological properties of an extremely selective beta 1-adrenoceptor antagonist, 2-[4-[3-(tert-Butylamino)-2-hydroxypropoxy] phenyl]-3-methyl-6-methoxy-4(3H)-quinazolinone [+/-)HX-CH 44 BS).
    Daemmgen JW, Engelhardt G, Pelzer H.
    Arzneimittelforschung; 1985 Oct; 35(1A):383-90. PubMed ID: 2859033
    [Abstract] [Full Text] [Related]

  • 17. Pharmacology of AH 5158; a drug which blocks both - and -adrenoceptors.
    Farmer JB, Kennedy I, Levy GP, Marshall RJ.
    Br J Pharmacol; 1972 Aug; 45(4):660-75. PubMed ID: 4404413
    [Abstract] [Full Text] [Related]

  • 18. In vitro studies on cetamolol, a new potent cardioselective beta-adrenoceptor blocking agent with intrinsic sympathomimetic activity.
    Grimes D, Stern M, Wojdan A, Cummings JR.
    Can J Physiol Pharmacol; 1983 Oct; 61(10):1109-15. PubMed ID: 6139156
    [Abstract] [Full Text] [Related]

  • 19. Partial agonist activity of celiprolol, a cardioselective beta-antagonist.
    Ochi S, Nakazawa M, Kimura T, Nakagawa Y, Imai S.
    Eur J Pharmacol; 1991 Feb 26; 194(1):1-5. PubMed ID: 1676370
    [Abstract] [Full Text] [Related]

  • 20. Beta-adrenoceptor blockade by atenolol, metoprolol and propranolol in the anaesthetized cat.
    Lundgren B, Carlsson E, Herrmann I.
    Eur J Pharmacol; 1979 May 01; 55(3):263-8. PubMed ID: 37096
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.